Celgene News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

04.06.18	FDA Nod For LLY/INCY RA Drug, JAZZ Hits Right Tones, SLS' Study Stopped Early (RTTNews)
03.06.18	Celgene Announces Additional Results From RELEVANCE (RTTNews)
01.06.18	Celgene Appoints J&J's David Elkins As EVP, CFO, Succeeding Peter Kellogg (RTTNews)
30.05.18	Evotec And Celgene Expand IPSC Collaboration To Include Addl Cell Lines (RTTNews)
25.05.18	CELGENE LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Celgene Corporation To Contact The Firm (PR Newswire)
24.05.18	Celgene Announces Addl $3 Bln Share Repurchase Authorization (RTTNews)
16.05.18	Hagens Berman Reminds Investors in Celgene Corporation (CELG) of the May 29, 2018 Securities Class Action Lead Plaintiff Deadline (PR Newswire)
04.05.18	Celgene Raises 2018 Revenue Guidance To High End Of Previous Range (RTTNews)
04.05.18	Celgene Corporation Q1 adjusted earnings Beat Estimates (RTTNews)
28.04.18	CELGENE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Celgene Corporation - CELG (PR Newswire)
24.04.18	PRTA Jolted, FDA Strikes Down PFE's Herceptin Biosimilar, No Relief Yet For KMDA (RTTNews)
07.04.18	CELGENE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against... (PR Newswire)
05.04.18	Long-Term Celgene (CELG) Investors: Johnson Fistel Investigates Celgene Corporation; Encourages Long-Term Investors to Contact the Firm (PR Newswire)
03.04.18	CELGENE INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Celgene Corporation To Contact The Firm (PR Newswire)
03.04.18	Celgene President And COO Scott Smith To Step Down (RTTNews)
30.03.18	SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Celgene Corporation (CELG) and Lead Plaintiff Deadline: May 29, 2018 (PR Newswire)
22.03.18	GERN Turning Heads, ARQL To Present Data In Apr., Mark Your Calendar For PTN (RTTNews)
21.03.18	S&P 500 Q4 2017 Buybacks Rose 6.0% to $137.0 Billion; Full-Year 2017 Fell 3.2% to $519.4 Billion (PR Newswire)
20.03.18	Lifshitz & Miller LLP Announces Investigation of Atlas Financial Holdings, Inc., Bellicum Pharmaceuticals, Inc., Celgene Corporation, Foot Locker, Inc., Kraton Corporation, Riot Blockchain, Inc. (PR Newswire)
06.03.18	Celgene Finalises Acquisition Of Juno Therapeutics (RTTNews)
01.03.18	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Celgene Corporation (CELG) (PR Newswire)
28.02.18	Celgene Seeing Significant Weakness In Afternoon Trading (RTTNews)
21.02.18	Celgene Gets Antitrust Clearance For Juno Therapeutics Acquisition (RTTNews)
15.02.18	Celularity Announces $250M in Funding to Deliver Treatments for Cancer, Inflammatory and Degenerative Diseases, and Functional Regeneration (PR Newswire)
15.02.18	In The Spotlight: AnaptysBio (RTTNews)
09.02.18	Celgene Prices $4.5 Bln Of Senior Unsecured Notes - Quick Facts (RTTNews)
06.02.18	Celgene Achieves Primary Endpoint For OPTIMISMM Phase III Study (RTTNews)
01.02.18	ZFGN Awaits Data, SLDB Makes Solid Gains, RCKT On Fire, SGEN Snaps Up CASC (RTTNews)
25.01.18	Celgene Corporation Bottom Line Rises In Q4 (RTTNews)
25.01.18	Earnings In Focus: Jan. 25 (MMM, AAL, CELG, INTC, SBUX) (RTTNews)
24.01.18	WeissLaw LLP Investigates Juno Therapeutics Inc. Acquisition (PR Newswire)
23.01.18	ARRY Shines A BEACON, So Long To JUNO And BIVV, Exciting Time Ahead For GEMP (RTTNews)
22.01.18	Celgene To Buy Juno Therapeutics In $9 Bln Deal; Reaffirms 2020 Targets (RTTNews)
18.01.18	JUNO Flies On Takeover Rumor, PRTO For Long Haul, SUPN Gaining Strength (RTTNews)
08.01.18	CELG Makes Blockbuster Purchase, MDXG, NBIX On Watch, Busy Year Ahead For ALNY (RTTNews)
08.01.18	Celgene To Buy Impact Biomedicines (RTTNews)
27.12.17	Celgene Moves To Downside On Downgrade By Bernstein (RTTNews)
11.12.17	Juno Therapeutics, Celgene Release Additional Data From TRANSCEND Trial (RTTNews)
30.10.17	FDA To Rule On Elagolix In Q2, More Light From CELG's RADIANCE, TGTX On Watch (RTTNews)
28.10.17	Celgene: Ozanimod Shows Superiority Versus Avonex In Phase III Trial (RTTNews)
27.10.17	NEOS Soars On Buyout Bid, INSY Plunges On Founder's Arrest, CELG Bleeds (RTTNews)
26.10.17	Celgene Updates 2017 Guidance - Quick Facts (RTTNews)
26.10.17	Celgene Corporation Bottom Line Climbs 24% In Q3 (RTTNews)
20.10.17	Celgene Remains Firmly Negative After Initial Sell-Off (RTTNews)
12.09.17	Companies to Watch as Biotech Makes a Comeback in 2017 (PR Newswire)
11.09.17	Little-Known Biotech Breakthrough Could Save Millions Of Lives (PR Newswire)
07.09.17	Celgene Says FDA Places Clinical Hold On FUSION Program (RTTNews)
07.09.17	New Drugs Approved In August (RTTNews)
06.09.17	Technical Reports on Biotech Equities -- Celgene, Dynavax Technologies, Keryx Biopharma, and Moleculin Biotech (PR Newswire)
29.08.17	Biotech Stocks Facing FDA Decision In September (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sika	218.60	0.64 %	K V
Sonova Hldg	300.80	0.64 %	K V
CieFinRichemont	139.90	0.25 %	K V
Alcon	76.44	0.08 %	K V
Kuehne+Nagel Int	202.80	-0.10 %	K V
Roche Hldg G	269.10	-0.99 %	K V
ABB	49.39	-1.16 %	K V
Holcim	87.96	-1.24 %	K V
UBS Group	29.98	-1.28 %	K V
Zurich Insur Gr	533.00	-1.30 %	K V

mehr

14:20		Bayer-Aktie profitiert: Niedrig dosiertes MRT-Kontrastmittel von Bayer besteht Phase-3-Studie
12:26		Zurückhaltung in London: FTSE 100 im Minus
12:26		Pluszeichen in Frankfurt: Am Mittag Gewinne im LUS-DAX
12:26		Freundlicher Handel in Europa: Am Mittag Pluszeichen im Euro STOXX 50
12:26		DAX-Handel aktuell: DAX-Börsianer greifen zu
10:02		DAX 40-Papier Bayer-Aktie: So viel hätte eine Investition in Bayer von vor 10 Jahren gekostet
09:29		Verluste in London: FTSE 100 fällt zum Start zurück
09.01.25		Pfizer-Aktie: Das sind die Analysten-Einstufungen des vergangenen Monats

14:20

Bayer-Aktie profitiert: Niedrig dosiertes MRT-Kontrastmittel von Bayer besteht Phase-3-Studie

12:26

Zurückhaltung in London: FTSE 100 im Minus

12:26

Pluszeichen in Frankfurt: Am Mittag Gewinne im LUS-DAX

12:26

Freundlicher Handel in Europa: Am Mittag Pluszeichen im Euro STOXX 50

12:26

DAX-Handel aktuell: DAX-Börsianer greifen zu

10:02

DAX 40-Papier Bayer-Aktie: So viel hätte eine Investition in Bayer von vor 10 Jahren gekostet